#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4845505	F	Antagonist activity at CXCR4 receptor in human CCRF-CEM cells assessed as inhibition of SDF-1alpha-induced calcium release preincubated for 25 mins followed by SDF-1alpha addition and monitered for 90 sec	Homo sapiens	15		cell-based format	Scientific Literature
2.	ALA4845506	B	Antagonist activity at muscarinic acetylcholine receptor in human CCRF-CEM cells assessed as inhibition of acetylcholine-induced calcium release preincubated for 25 mins followed by acetylcholine addition and monitered for 90 sec	Homo sapiens	15		cell-based format	Scientific Literature
3.	ALA4845507	A	Metabolic stability in human liver microsomes assessed as parent compound remaining incubated for 10 mins in presence of NADPH	Homo sapiens	15		microsome format	Scientific Literature
4.	ALA4845508	A	Metabolic stability in rat liver microsomes assessed as parent compound remaining incubated for 10 mins in presence of NADPH	Rattus norvegicus	15		microsome format	Scientific Literature
5.	ALA4845509	A	Metabolic stability in mouse liver microsomes assessed as parent compound remaining incubated for 10 mins in presence of NADPH	Mus musculus	15		microsome format	Scientific Literature
6.	ALA4845510	A	Inhibition of human recombinant CYP2D6 expressed in insect cells using AMMC as substrate preincubated for 30 mins followed by NADPH regenerating system addition and measured after 45 mins by fluorescence based assay	Homo sapiens	15		cell-based format	Scientific Literature
7.	ALA4845511	A	Permeability of the compound at pH 7.4 incubated for 4 hrs by PAMPA		9		assay format	Scientific Literature
8.	ALA4845512	A	Inhibition of CYP3A4 (unknown origin)	Homo sapiens	15		single protein format	Scientific Literature
9.	ALA4845514	A	Cmax in CD-1 mouse at 30 mg/kg, po or at 3 mg/kg, iv by UPLC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
10.	ALA4845515	A	Cmax in CD-1 mouse at 30 mg/kg, po or at 3 mg/kg, iv measured up to 8 hrs by UPLC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
11.	ALA4845516	A	Clearance in CD-1 mouse at 30 mg/kg, po or at 3 mg/kg, iv by UPLC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
12.	ALA4845517	A	Volume of distribution in CD-1 mouse at 30 mg/kg, po or at 3 mg/kg, iv by UPLC-MS/MS analysis	Mus musculus	2		organism-based format	Scientific Literature
13.	ALA4845520	A	AUC (0 to t) in CD-1 mouse at 30 mg/kg, po or at 3 mg/kg, iv measured after 8 hrs by LC-MS/MS analysis	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA4845521	A	Half life in CD1 mouse at 30 mg/kg, po or at 3 mg/kg, iv measured after 8 hrs by LC-MS/MS analysis	Mus musculus	1		organism-based format	Scientific Literature
15.	ALA4845522	A	Oral bioavailability in CD1 mouse at 30 mg/kg measured after 8 hrs by LC-MS/MS analysis	Mus musculus	1		organism-based format	Scientific Literature
16.	ALA4845523	F	Antagonist activity at CXCR1 (unknown origin) assessed as inhibition of ligand-induced calcium flux measured upto 10 uM	Homo sapiens	1		assay format	Scientific Literature
17.	ALA4845524	F	Antagonist activity at CXCR2 (unknown origin) assessed as inhibition of ligand-induced calcium flux measured upto 10 uM	Homo sapiens	1		assay format	Scientific Literature
18.	ALA4845525	F	Antagonist activity at CXCR3 (unknown origin) assessed as inhibition of ligand-induced calcium flux measured upto 10 uM	Homo sapiens	1		assay format	Scientific Literature
19.	ALA4845526	F	Antagonist activity at CCR4 (unknown origin) assessed as inhibition of ligand-induced calcium flux measured upto 10 uM	Homo sapiens	1		assay format	Scientific Literature
20.	ALA4845527	F	Antagonist activity at CCR5 (unknown origin) assessed as inhibition of ligand-induced calcium flux measured upto 10 uM	Homo sapiens	1		assay format	Scientific Literature